- Global Pharma News & Resources

Bond Digital Health launches crowdfunding campaign with Seedrs

Fast-growing medtech firm Bond Digital Health has launched a crowdfunding campaign to complete a £1.5m funding round.


The Cardiff-based company has already secured £1.3m in the round, with £420,000 from the Development Bank of Wales and the remainder through the investment service Wealth Club.


Now it is offering individual investors the chance to join a fast-growing and disruptive business at the start of its scale-up journey by becoming a Bond Digital Health shareholder.


Bond has launched the campaign with Seedrs, an equity crowdfunding platform headquartered in London that makes it easy for individuals to buy into the businesses they believe in and share in their success.


Bond’s CEO Ian Smith said: “We've already enjoyed great support from current shareholders in securing £1.3m of our £1.5m funding round.


“We are delighted to now launch a Seedrs campaign to raise the allocation reserved for individual investors.


“This is an exciting opportunity to invest in the continued success of Bond Digital Health and to become part of our mission to make healthcare better with data.


“We believe digitised point-of-care diagnostics have the power to transform healthcare, making it more accessible across the world.


“Now, individual investors can help us make it happen by becoming part of our shareholder community.”


In 2020, Bond received almost £2 million in equity funding and more than £200,000 in UK and Welsh Government grants, which allowed it to expand its development team and bring its key product, Transform®, to market.


Transform® is an award-winning data capture and management platform for lateral flow and other point-of-care diagnostic tests.


It allows users to capture and manage test results and other data in real-time on an easy-to-use app, cloud, and dashboard system.


For more information, visit

Editor Details

Last Updated: 11-May-2022